|
GB1583602A
(en)
*
|
1977-05-26 |
1981-01-28 |
Sterwin Ag |
N-acetyl-para-aminophenyl-n'-acetyl-amino-thioalkanoic acid ester derivatives
|
|
IT1194117B
(it)
*
|
1981-11-20 |
1988-09-14 |
Isnardi Pietro & C Spa |
Derivati salicilici di n-acetilcisteina
|
|
IT1190987B
(it)
*
|
1982-09-07 |
1988-02-24 |
Pharma Edmond Srl |
Tioesteri dell'acido acetilsalicilico,procedimento per la loro preparazione e composizioni farmaceutiche che li conttengono
|
|
IT1206515B
(it)
*
|
1983-08-09 |
1989-04-27 |
Guidotti & C Spa Labor |
N-acetilcisteina ederivati 2',4's-carbossimetilcisteina ad-difluoro-4-idrossi-(1,1'-bifenil)attivita' antinfiammatoria, 3-carbossilici della mucolitica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
|
|
US5948769A
(en)
*
|
1984-01-28 |
1999-09-07 |
Ismail; Roshdy |
Agent for treating heart diseases
|
|
EP0254032A3
(en)
*
|
1986-06-20 |
1990-09-05 |
Schering Corporation |
Neutral metalloendopeptidase inhibitors in the treatment of hypertension
|
|
US5610180A
(en)
*
|
1988-01-29 |
1997-03-11 |
Virginia Commonwealth University |
Ionizable congeners of aromatic and aliphatic alcohols as anti-leukemia agents
|
|
JPH04217916A
(ja)
*
|
1990-06-21 |
1992-08-07 |
Japan Tobacco Inc |
抗炎症剤
|
|
US8178516B2
(en)
*
|
1992-06-30 |
2012-05-15 |
Sylvan Labs, LLC |
Compositions and method for treatment of chronic inflammatory diseases
|
|
DE4444051A1
(de)
*
|
1994-12-10 |
1996-06-13 |
Rhone Poulenc Rorer Gmbh |
Pharmazeutische, oral anwendbare Zubereitung
|
|
US5871769A
(en)
*
|
1996-01-18 |
1999-02-16 |
Fleming & Company, Pharmaceuticals |
Methods and compositions for the prevention and treatment of diabetes mellitus
|
|
WO1998011066A1
(en)
*
|
1996-09-10 |
1998-03-19 |
Medinox, Inc. |
Polydithiocarbamate-containing macromolecules and the use thereof for therapeutic and diagnostic applications
|
|
ITMI962356A1
(it)
*
|
1996-11-13 |
1998-05-13 |
Uni Degli Studi Di Brescia D I |
Uso di composti derivati da molecole ad attivita' antinfiammatoria di tipo non steroideo per la prevenzione e il trattamento di
|
|
US6896899B2
(en)
*
|
1996-12-31 |
2005-05-24 |
Antioxidant Pharmaceuticals Corp. |
Pharmaceutical preparations of glutathione and methods of administration thereof
|
|
AU728488B2
(en)
*
|
1997-04-02 |
2001-01-11 |
Sankyo Company Limited |
Dithiolan derivatives, their preparation and their therapeutic effect
|
|
CA2285091A1
(en)
*
|
1997-04-02 |
1998-10-08 |
Brigham And Women's Hospital, Inc. |
Means of ascertaining an individual's risk profile for atherosclerotic disease
|
|
AUPO612397A0
(en)
*
|
1997-04-11 |
1997-05-08 |
University Of Queensland, The |
Novel diflunisal esters and related compounds
|
|
DE69829966T2
(de)
*
|
1997-05-14 |
2006-02-09 |
Atherogenics, Inc. |
Ein monoether von probucol und methoden zur hemmung der vcam-1 expression
|
|
US6852878B2
(en)
*
|
1998-05-14 |
2005-02-08 |
Atherogenics, Inc. |
Thioketals and thioethers for inhibiting the expression of VCAM-1
|
|
US20020004515A1
(en)
*
|
1997-06-18 |
2002-01-10 |
Smith Stephen Alistair |
Treatment of diabetes with thiazolidinedione and metformin
|
|
US5972986A
(en)
*
|
1997-10-14 |
1999-10-26 |
G.D. Searle & Co. |
Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
|
|
US5905090A
(en)
*
|
1998-04-29 |
1999-05-18 |
Italfarmaco S.P.A. |
Analogues of the active metabolite of leflunomide
|
|
US6197340B1
(en)
*
|
1998-05-28 |
2001-03-06 |
Medical Research Institute |
Controlled release lipoic acid
|
|
EP1085846A2
(en)
*
|
1998-06-08 |
2001-03-28 |
Advanced Medicine, Inc. |
Multibinding inhibitors of microsomal triglyceride transferase protein
|
|
CA2339218C
(en)
*
|
1998-07-31 |
2008-10-28 |
Mount Sinai Hospital |
Methods and compositions for increasing insulin sensitivity
|
|
US20020045580A1
(en)
*
|
1999-11-24 |
2002-04-18 |
Sacks Meir S. |
Compositions for raising uric acid levels and methods of using same
|
|
AU6044699A
(en)
*
|
1998-09-17 |
2000-04-03 |
Akesis Pharmaceuticals, Inc. |
Compositions and methods for treatment of glucose metabolism disorders
|
|
US6201028B1
(en)
*
|
1998-12-08 |
2001-03-13 |
The Rockefeller University |
Methods and compositions for prevention and treatment of atherosclerosis and hyperlipidemia with non-steroidal anti-inflammatory drugs
|
|
EP1166786A4
(en)
*
|
1999-01-20 |
2004-05-12 |
Takara Bio Inc |
MEDICAL COMPOSITIONS
|
|
JP2007326864A
(ja)
*
|
1999-01-20 |
2007-12-20 |
Takara Bio Inc |
医薬組成物
|
|
IT1311924B1
(it)
*
|
1999-04-13 |
2002-03-20 |
Nicox Sa |
Composti farmaceutici.
|
|
US20010051184A1
(en)
*
|
1999-05-20 |
2001-12-13 |
Madalene C.Y. Heng |
Method for using soluble curcumin to inhibit phosphorylase kinase in inflammatory diseases
|
|
JP4618845B2
(ja)
*
|
1999-06-09 |
2011-01-26 |
杏林製薬株式会社 |
ヒトペルオキシゾーム増殖薬活性化受容体（ＰＰＡＲ）αアゴニストとしての置換フェニルプロピオン酸誘導体
|
|
CA2377414A1
(en)
*
|
1999-06-15 |
2000-12-21 |
John D. Potter |
Nutrient formulations for disease reduction, and related treatment and component screening methods
|
|
US6309663B1
(en)
*
|
1999-08-17 |
2001-10-30 |
Lipocine Inc. |
Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
|
|
AU7995300A
(en)
*
|
1999-10-05 |
2001-05-10 |
Bethesda Pharmaceuticals, Inc. |
Dithiolane derivatives
|
|
US7323496B2
(en)
*
|
1999-11-08 |
2008-01-29 |
Theracos, Inc. |
Compounds for treatment of inflammation, diabetes and related disorders
|
|
US20020155163A1
(en)
*
|
1999-12-27 |
2002-10-24 |
Samuel D. Benjamin |
Integrated multi-vitamin and mineral combination
|
|
US20080213785A1
(en)
*
|
2000-04-20 |
2008-09-04 |
Andrew Levy |
Method of predicting a benefit of antioxidant therapy for prevention or treatment of vasclar disease in hyperglycemic individuals
|
|
US20080044399A1
(en)
*
|
2000-04-20 |
2008-02-21 |
Andrew Levy |
Vitamin E supplementation for reducing cardiovascular events in individuals with DM and the Hp 2-2 genotype
|
|
US20020037855A1
(en)
*
|
2000-05-05 |
2002-03-28 |
Fritz Stanislaus |
Stabilized medicament containing cysteinyl derivatives
|
|
US6355666B1
(en)
*
|
2000-06-23 |
2002-03-12 |
Medinox, Inc. |
Protected forms of pharmacologically active agents and uses therefor
|
|
US6429223B1
(en)
*
|
2000-06-23 |
2002-08-06 |
Medinox, Inc. |
Modified forms of pharmacologically active agents and uses therefor
|
|
US6365176B1
(en)
*
|
2000-08-08 |
2002-04-02 |
Functional Foods, Inc. |
Nutritional supplement for patients with type 2 diabetes mellitus for lipodystrophy
|
|
IT1319201B1
(it)
*
|
2000-10-12 |
2003-09-26 |
Nicox Sa |
Farmaci per il diabete.
|
|
US20020098247A1
(en)
*
|
2000-11-02 |
2002-07-25 |
Komorowski James R. |
Methods and compositions for the improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes and alpha lipoic acid
|
|
US6589948B1
(en)
*
|
2000-11-28 |
2003-07-08 |
Eukarion, Inc. |
Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases
|
|
UA80393C2
(uk)
*
|
2000-12-07 |
2007-09-25 |
Алтана Фарма Аг |
Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
|
|
WO2002048715A2
(en)
*
|
2000-12-14 |
2002-06-20 |
The Brigham And Women's Hospital, Inc. |
Inflammatory markers for detection and prevention of diabetes mellitus
|
|
WO2004096256A1
(en)
*
|
2001-01-23 |
2004-11-11 |
The United States Of America, As Represented By The Secretary Of The Navy |
Methods for preventing and treating loss of balance function due to oxidative stress
|
|
JP2002226457A
(ja)
*
|
2001-02-02 |
2002-08-14 |
Ajinomoto Co Inc |
新規シスチン誘導体及び炎症因子活性化抑制剤
|
|
US6566401B2
(en)
*
|
2001-03-30 |
2003-05-20 |
The Board Of Trustees Of The Leland Stanford Junior University |
N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
|
|
US7560442B2
(en)
*
|
2001-04-30 |
2009-07-14 |
Trommsdorff Gmbh & Co. Kg Arzneimittel |
Pharmaceutically active uridine esters
|
|
US6669955B2
(en)
*
|
2001-08-28 |
2003-12-30 |
Longwood Pharmaceutical Research, Inc. |
Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin
|
|
EP1429734B1
(en)
*
|
2001-09-21 |
2007-12-26 |
Egalet A/S |
Controlled release solid dispersions of carvedilol
|
|
US7670612B2
(en)
*
|
2002-04-10 |
2010-03-02 |
Innercap Technologies, Inc. |
Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
|
|
US6960683B2
(en)
*
|
2002-07-12 |
2005-11-01 |
Atherogenics, Inc. |
Salt forms of poorly soluble probucol esters and ethers
|
|
US7148211B2
(en)
*
|
2002-09-18 |
2006-12-12 |
Genzyme Corporation |
Formulation for lipophilic agents
|
|
ES2411961T5
(es)
*
|
2002-11-01 |
2017-04-27 |
Rutgers, The State University Of New Jersey |
Vehículos de suministro en forma de geoda
|
|
US8093292B2
(en)
*
|
2002-11-22 |
2012-01-10 |
Bionexus, Ltd. |
Methods for the treatment of HIV-1 related fat maldistribution, fasting hyperlipidemia and modification of adipocyte physiology
|
|
US8017651B2
(en)
*
|
2002-11-22 |
2011-09-13 |
Bionexus, Ltd. |
Compositions and methods for the treatment of HIV-associated fat maldistribution and hyperlipidemia
|
|
MXPA02012315A
(es)
*
|
2002-12-13 |
2004-06-24 |
Univ Autonoma Metropolitana |
Compuesto farmaceutico que contiene silimarina y carbopol, su proceso de fabricacion y su uso como regenerador del tejido y celulas pancreaticas de secrecion endogena danados por diabetes mellitus.
|
|
US20090036516A1
(en)
*
|
2003-01-13 |
2009-02-05 |
Ctg Pharma S.R.L. |
Compounds for treating metabolic syndrome
|
|
WO2006066894A1
(en)
*
|
2004-12-24 |
2006-06-29 |
Ctg Pharma S.R.L. |
Compounds for treating metabolic syndrome
|
|
WO2004082621A2
(en)
*
|
2003-03-15 |
2004-09-30 |
Bethesda Pharmaceuticals, Inc. |
Novel ppar agonists, pharmaceutical compositions and uses thereof
|
|
US7981915B2
(en)
*
|
2003-04-30 |
2011-07-19 |
Beth Israel Deaconess Medical Center |
Methods for modulating PPAR biological activity for the treatment of diseases caused by mutations in the CFTR gene
|
|
AT500404A1
(de)
*
|
2003-07-17 |
2005-12-15 |
Jsw Res Forschungslabor Gmbh |
Chemische verbindungen enthaltend tocopherol sowie zumindest einen weiteren pharmazeutischen wirkstoff
|
|
US8173840B2
(en)
*
|
2003-07-29 |
2012-05-08 |
Signature R&D Holdings, Llc |
Compounds with high therapeutic index
|
|
US20070254055A1
(en)
*
|
2003-11-21 |
2007-11-01 |
Trustees Of Tufts College |
Therapeutic Avenanthramide Compounds
|
|
US7078064B2
(en)
*
|
2003-12-03 |
2006-07-18 |
George Zabrecky |
Compositions and methods useful for treating and preventing chronic liver disease, chronic HCV infection and non-alcoholic steatohepatitis
|
|
US20050143356A1
(en)
*
|
2003-12-08 |
2005-06-30 |
Vanderbilt University |
Selective inhibition of cyclooxygenase 1 in the treatment of diabetic nephropathy
|
|
CN1956726B
(zh)
*
|
2004-03-23 |
2011-04-13 |
生命线营养健康公司 |
用于缓解哺乳动物炎症及氧化应激的组合物和方法
|
|
WO2005112914A2
(en)
*
|
2004-04-20 |
2005-12-01 |
Atherogenics, Inc. |
Phenolic antioxidants for the treatment of disorders including arthritis, asthma and coronary artery disease
|
|
JP2007538083A
(ja)
*
|
2004-05-17 |
2007-12-27 |
コンビナトアールエックス インコーポレーティッド |
免疫炎症性障害の治療のための方法および試薬
|
|
WO2006004803A1
(en)
*
|
2004-06-30 |
2006-01-12 |
Combinatorx, Incorporated |
Methods and reagents for the treatment of metabolic disorders
|
|
JP2008508348A
(ja)
*
|
2004-08-02 |
2008-03-21 |
ジェンメディカ・セラピューティックス・ソシエダッド・リミターダ |
銅含有アミンオキシダーゼを阻害するための化合物およびその使用
|
|
US8252321B2
(en)
*
|
2004-09-13 |
2012-08-28 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
|
|
US20080038316A1
(en)
*
|
2004-10-01 |
2008-02-14 |
Wong Vernon G |
Conveniently implantable sustained release drug compositions
|
|
JPWO2006043671A1
(ja)
*
|
2004-10-22 |
2008-05-22 |
キリンホールディングス株式会社 |
転写因子Ｎｒｆ２活性化剤およびその機能が付与された食品
|
|
US20060099279A1
(en)
*
|
2004-11-09 |
2006-05-11 |
Council Of Scientific & Industrial Research |
Novel anti-diabetic herbal formulation
|
|
CA2584845C
(en)
*
|
2004-12-08 |
2009-02-17 |
Sirion Therapeutics, Inc. |
Methods, assays and compositions for treating retinol-related diseases
|
|
US20060166901A1
(en)
*
|
2005-01-03 |
2006-07-27 |
Yu Ruey J |
Compositions comprising O-acetylsalicyl derivatives of aminocarbohydrates and amino acids
|
|
CA2595486A1
(en)
*
|
2005-01-20 |
2006-07-27 |
Sirtris Pharmaceuticals, Inc. |
Use of sirtuin-activating compounds for treating flushing and drug induced weight gain
|
|
US20060172012A1
(en)
*
|
2005-01-28 |
2006-08-03 |
Finley John W |
Anti-inflammatory supplement compositions and regimens to reduce cardiovascular disease risks
|
|
US20080033027A1
(en)
*
|
2005-03-21 |
2008-02-07 |
Vicus Therapeutics Spe 1, Llc |
Drug combination pharmaceutical compositions and methods for using them
|
|
JP2008538586A
(ja)
*
|
2005-04-21 |
2008-10-30 |
グレン エー． ゴールドスタイン， |
酸化ストレスに関連する疾患および病気の処置のためのｎ−アセチルシステインアミド（ｎａｃアミド）
|
|
US20060270635A1
(en)
*
|
2005-05-27 |
2006-11-30 |
Wallace John L |
Derivatives of 4- or 5-aminosalicylic acid
|
|
US20070149466A1
(en)
*
|
2005-07-07 |
2007-06-28 |
Michael Milburn |
Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
|
|
WO2007025613A2
(en)
*
|
2005-07-15 |
2007-03-08 |
Laboratorios Del Dr. Esteve, S.A. |
Use of compounds binding to the sigma receptor for the treatment of diabetes-associated pain
|
|
WO2007011958A2
(en)
*
|
2005-07-15 |
2007-01-25 |
Emisphere Technologies, Inc. |
Intraoral dosage forms of glucagon
|
|
ES2397275T3
(es)
*
|
2005-08-04 |
2013-03-05 |
Sirtris Pharmaceuticals, Inc. |
Derivados de imidazopiridina como agentes moduladores de la sirtuína
|
|
WO2007056281A2
(en)
*
|
2005-11-03 |
2007-05-18 |
Ilypsa, Inc. |
Multivalent indole compounds and use thereof as phospholipase-a2 inhibitors
|
|
AU2006339607A1
(en)
*
|
2005-12-02 |
2007-09-13 |
Sirtris Pharmaceuticals, Inc. |
Modulators of Cdc2-like kinases (Clks) and methods of use thereof
|
|
JP2009518415A
(ja)
*
|
2005-12-05 |
2009-05-07 |
バイオマリン ファーマシューティカル インコーポレイテッド |
疾患の処置のための方法および組成物
|
|
EP1968559A4
(en)
*
|
2005-12-09 |
2013-08-07 |
Metaproteomics Llc |
INFLAMMATORY BOTANICAL PRODUCTS FOR THE TREATMENT OF METABOLIC SYNDROME AND DIABETES
|
|
US7814420B2
(en)
*
|
2005-12-14 |
2010-10-12 |
Honeywell International Inc. |
System and method for providing context sensitive help information
|
|
JP2007176799A
(ja)
*
|
2005-12-27 |
2007-07-12 |
Sankyo Co Ltd |
置換ベンゼン化合物を含有する医薬
|
|
US20070231273A1
(en)
*
|
2006-03-31 |
2007-10-04 |
Jie Wu |
Method for Decreasing Blood Glucose Levels
|
|
US20080015251A1
(en)
*
|
2006-04-10 |
2008-01-17 |
Yissum Research Development Co., Of The Hebrew University Of Jerusalem |
Means and method for treating lipotoxicity and other metabolically related phenomena
|
|
US7629158B2
(en)
*
|
2006-06-16 |
2009-12-08 |
The Procter & Gamble Company |
Cleaning and/or treatment compositions
|
|
US20080139525A1
(en)
*
|
2006-08-31 |
2008-06-12 |
The Brigham And Women's Hospital, Inc. |
Antioxidant therapies
|
|
JP2010521135A
(ja)
*
|
2006-10-06 |
2010-06-24 |
セルタクシス，インコーポレイテッド |
細胞の化学忌避
|
|
US7498048B2
(en)
*
|
2006-11-16 |
2009-03-03 |
Jose Angel Olalde Rangel |
Renal phyto-nutraceutical composition
|
|
TR201802359T4
(tr)
*
|
2007-01-16 |
2018-03-21 |
Ipintl Llc |
Metabolik sendromun tedavi edilmesine yönelik yeni bileşim.
|
|
US20090169497A1
(en)
*
|
2007-12-31 |
2009-07-02 |
Horwitz Lawrence D |
Treatment and Prevention of Skin Injury Due to Exposure to Ultraviolet Light
|
|
JP2012520343A
(ja)
*
|
2009-03-16 |
2012-09-06 |
ジェンメディカ・セラピューティックス・ソシエダッド・リミターダ |
代謝障害治療のための併用療法
|